Cadila to manufacture ELISA antibody test kits

Zydus Cadila, a part of Cadila Healthcare has informed the bourses that it is going to manufacture-‘COVID Kavach Elisa’, the first indigenously developed IgG ELISA test for antibody detection by Indian Council of Medical Research (ICMR) ‐National Institute of Virology (NIV) at Pune.

ICMR‐NIV (Pune) has successfully developed an indigenous IgG ELISA test for antibody detection for COVID‐19.

The test was validated at two sites in Mumbai and has been found to have high sensitivity and specificity. In addition, the test will have the advantage of testing 90 samples together in a single run of 2.5 hours. Besides, ELISA-based testing is easily possible even at the district level. After development at ICMR‐NIV (Pune), the technology has been transferred to Zydus Cadila for mass-scale production.

The kits will be manufactured through a technology transfer by Cadila Healthcare at Moraiya (Gujarat).

Headquartered in Gujarat, the company is engaged in manufacturing drugs and is one of the leading pharmaceutical companies in India.

Today, the stock of Cadila jumped by four per cent and made an intraday high of Rs 333.70 on BSE.